Ephx2 -gene deletion affects acetylcholine-induced relaxation in angiotensin-II infused mice: role of nitric oxide and CYP-epoxygenases

作者: Ahmad Hanif , Matthew L. Edin , Darryl C. Zeldin , Mohammed A. Nayeem

DOI: 10.1007/S11010-019-03665-X

关键词:

摘要: Previously, we showed that adenosine A2A receptor induces relaxation independent of NO in soluble epoxide hydrolase-null mice (Nayeem et al. Am J Physiol Regul Integr Comp 304:R23–R32, 2013). Currently, hypothesize Ephx2-gene deletion affects acetylcholine (Ach)-induced which is A2AAR but dependent on and CYP-epoxygenases. Ephx2−/− aortas a lack sEH (97.1%, P   0.05). Ach-induced response was tested with nitro-l-arginine methyl ester (l-NAME) NO-inhibitor; 10−4 M), N-(methylsulfonyl)-2-(2-propynyloxy)-benzenehexanamide (MS-PPOH) (CYP-epoxygenase inhibitor; 10−5 M), 14,15-epoxyeicosa-5(Z)-enoic acid (14,15-EEZE, an epoxyeicosatrienoic acid-antagonist; SCH-58261 (A2AAR-antagonist; 10−6 M), angiotensin-II (Ang-II, 10−6 M). In mice, not different from C57Bl/6 except at 10−5 M (92.75 ± 2.41 vs. 76.12 ± 3.34,  0.05) non-treated (P > 0.05). Interestingly, Ang-II attenuates less Ehx2−/− (58.80 ± 7.81% 45.92 ± 7.76, P < 0.05). Our data suggest depends CYP-epoxygenases AR, Ang-II-infused mice.

参考文章(70)
Vishal R Yadav, Mohammed A Nayeem, Stephen L Tilley, S Jamal Mustafa, Angiotensin II stimulation alters vasomotor response to adenosine in mouse mesenteric artery: role for A1 and A2B adenosine receptors. British Journal of Pharmacology. ,vol. 172, pp. 4959- 4969 ,(2015) , 10.1111/BPH.13265
Beate Fisslthaler, Rüdiger Popp, Ladislau Kiss, Michael Potente, David R. Harder, Ingrid Fleming, Rudi Busse, Cytochrome P450 2C is an EDHF synthase in coronary arteries Nature. ,vol. 401, pp. 493- 497 ,(1999) , 10.1038/46816
Ding Ai, Yi Fu, Deliang Guo, Hiromasa Tanaka, Nanping Wang, Chaoshu Tang, Bruce D Hammock, John Y-J Shyy, Yi Zhu, None, Angiotensin II up-regulates soluble epoxide hydrolase in vascular endothelium in vitro and in vivo. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 104, pp. 9018- 9023 ,(2007) , 10.1073/PNAS.0703229104
Darryl C Zeldin, James K Liao, Reply: cytochrome P450-derived eicosanoids and the vascular wall. Trends in Pharmacological Sciences. ,vol. 21, pp. 127- 128 ,(2000) , 10.1016/S0165-6147(00)01454-1
Katherine N Theken, Craig R Lee, Genetic variation in the cytochrome P450 epoxygenase pathway and cardiovascular disease risk Pharmacogenomics. ,vol. 8, pp. 1369- 1383 ,(2007) , 10.2217/14622416.8.10.1369
Koichi Node, Yuqing Huo, Xiulu Ruan, Baichun Yang, Martin Spiecker, Klaus Ley, Darryl C Zeldin, James K Liao, Anti-inflammatory Properties of Cytochrome P450 Epoxygenase-Derived Eicosanoids Science. ,vol. 285, pp. 1276- 1279 ,(1999) , 10.1126/SCIENCE.285.5431.1276
K. R. Schmelzer, L. Kubala, J. W. Newman, I.-H. Kim, J. P. Eiserich, B. D. Hammock, Soluble epoxide hydrolase is a therapeutic target for acute inflammation. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 102, pp. 9772- 9777 ,(2005) , 10.1073/PNAS.0503279102
Swati S. Kunduri, S. Jamal Mustafa, Dovenia S. Ponnoth, Gregory M. Dick, Mohammed A. Nayeem, Adenosine A1 receptors link to smooth muscle contraction via CYP4a, protein kinase C-α, and ERK1/2. Journal of Cardiovascular Pharmacology. ,vol. 62, pp. 78- 83 ,(2013) , 10.1097/FJC.0B013E3182919591
Zuzana Honetschlägerová, Alexandra Sporková, Libor Kopkan, Zuzana Husková, Sung H Hwang, Bruce D Hammock, John D Imig, Herbert J Kramer, Petr Kujal, Zdenka Vernerová, Veˇra Cˇ Chabova, Vladimír Tesar, Ludeˇk Cˇervenka, Inhibition of soluble epoxide hydrolase improves the impaired pressure-natriuresis relationship and attenuates the development of hypertension and hypertension-associated end-organ damage in Cyp1a1-Ren-2 transgenic rats. Journal of Hypertension. ,vol. 29, pp. 1590- 1601 ,(2011) , 10.1097/HJH.0B013E328349062F